Ticker Details
STAAR Surgical Company Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.
IPO Date:	March 2, 1992
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.25B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.56 | 2.46%
Avg Daily Range (30 D):	$0.57 | 3.02%
Avg Daily Range (90 D):	$0.56 | 2.68%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	1.19M
Avg Daily Volume (90 D):	1.29M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	3,886
Avg Institutional Trade:	$2.7M
Avg Institutional Trade (30 D):	$2.31M
Avg Institutional Trade (90 D):	$1.98M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.34M
Avg Closing Trade (30 D):	$3.08M
Avg Closing Trade (90 D):	$2.54M
Avg Closing Volume:	73.51K

News

Apr 9, 2026 @ 7:35 AM Why Did STAAR Surgical (STAA) Stock Jump 20% After... Source: Mohd Haider

Mar 17, 2026 @ 1:04 PM LENSAR Stock Plunges—Alcon Scraps Merger Af... Source: Vandana Singh

Feb 18, 2026 @ 10:18 AM FDA Expands Approval For Staar Surgical's Popular ... Source: Vandana Singh

Jan 15, 2026 @ 6:06 PM STAAR Surgical Stock Falls After Largest Sharehold... Source: Vandana Singh

Jan 14, 2026 @ 3:00 PM LASIK Eye Surgery Market Size to Reach USD 3.77 Bi... Source: Sns Insider

Financials
	TTM	Q4 2025	FY 2025
Basic EPS		$-.36	$-1.62
Diluted EPS		$-.36	$-1.62
Revenue		$57.8M	$239.44M
Gross Profit		$43.74M	$182.42M
Net Income / Loss		$-18.31M	$-80.45M
Operating Income / Loss		$-22.84M	$-91.71M
Cost of Revenue		$14.06M	$57.02M
Net Cash Flow		$-23.01M	$8.99M
PE Ratio